• Fast bacterial and viral infection treatments
  • Direct constant-current silver ion delivery technology can target even hard-to-reach infections anywhere in the body
  • Effective against antibiotic-resistant superbugs
  • Leading replacement of antibiotics and antiviral drugs
  • Also treats yeast and fungal infections
  • Reduces pain
  • 100% noninvasive
  • No drug side effects or risks
  • Easy to apply—no expertise necessary
  • Patent pending device & technology


  • For surface wounds and internal scar tissue
  • Direct constant-current silver ion delivery to the wound for treatment and prevention of infection
  • Self-adapts to the individual wound—measures, replaces or supplements in real-time the controlling bioelectric signal of wound healing
  • Self-adapts to electrode↔wound positioning
  • Reduces pain
  • Stimulates FB cells in the wound to self-modify with the regrowth abilities of stem cells for tissue regeneration and less scarring
  • Patent pending device & technology



  • World's first generally available silver-nylon iontophoresis electrode
  • 4 years in research and clinical testing
  • 99+% pure silver-plated—high ionic silver release
  • Higher conductivity than standard electrotherapy electrodes
  • Parallel cross-development of specifications with SIS machines


  • World's first generally available silver iontophoresis electro-stimulators
  • 7 years clinical and data-based development
  • 2 years electronics design and development
  • Major global medical need driven innovation
  • 'Smart' self-adaptive software algorithms monitor SIS electrode contact with the body
  • Each SIS machine assembled and calibrated in Australia


View and download SIS equipment application diagrams and videos, clinical results and user testimonials.



Superbugs and growing antibiotic resistance
Common superbugs include Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus (VRE), Carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant (MDR) Pseudomonas aeruginosa.
Even after several decades of use of silver in medical dressings and topical creams, there is either none, or very little evidence of resistance of bacteria to electrically generated silver ions.

Together with the established effects on microorgansisms of low intesity direct current (LIDC) generated by the SIS machines, and the potential 'dielectrophoretic' effects of the silver ion on infected cells, the concept of drug resistance might not ever apply with use of the SIS technology. Read more >

Drug and therapeutic substance delivery problems
Inflammation and blood flow disturbances often exist in and around infected areas of the body, including to chronic wounds, restricting drug uptake. There are also many hard-to-reach locations of infections, due to the body's natural anatomical compartments and barriers—from large to microscopic scale, and in the presence of prosthetic implants.
Silver iontophoresis does not depend on blood flow. The direct constant-current silver ion delivery of the SIS machines, operating on the basic physics of electric voltages and currents, travels via the shortest possible route directly to the infected area.

Antibiotics and antivirals overdosing problems
To reach localized infections, especially in peripheries of the body, the entire body has to be unnecessarily loaded with antibiotics or antiviral drugs.
The M200 model SIS machine operates with ultra-low microcurrent, calibrated with extreme precision to the SIS electrodes; only the minimum necessary ionic direct current (DC) is delivered, directly to the targeted infected area.

Antibiotics side effects and reactions increasingly common
Digestive system disruption: vomiting, nausea, diarrhoea, bloating and indigestion, abdominal pain, loss of appetite.

Allergic reactions: itchy skin rashes (hives), coughing, wheezing, tightness of the throat and breathing difficulties—needing more drugs to suppress.

Possible life-threatening allergic reaction (anaphylaxis): multiple symptoms including swelling and tightening of the neck, drop in blood pressure and loss of consciousness.

Risks of severe long-term nerve damage (peripheral neuropathy): from Fluoroquinolone antibiotics—Levaquin (levofloxacin), Cipro (ciprofloxacin), Avelox (moxifloxacin), Noroxin (norfloxacin), Floxin (ofloxacin) and Factive (gemifloxacin).
The silver ions released from the SIS electrodes have none of these drug side effects or risks.

Spectrum of activity
Antibiotics are classed as either narrow or broad spectrum, based on the range of bacterial species susceptible to these drugs.
Electrically generated silver ions are super-broad spectrum agents, for both gram-negative and gram-positive type bacteria.

No or few drugs for viruses with major side effects and risks
Only a small number of drugs exist for the treatment of some viral infections. These drugs can have many, serious side effects, including organ failure, cardiac arrest, psychological disturbance, and confirmed fatalities. Drug delivery is also limited by the same uptake and overdosing problems of antibiotics (read above). The newer "direct-acting" antiviral drugs for hepatitis treatment, carry the highest category USA Food and Drug Administration (FDA) 'black box' warnings due to lethal side-effects.
The SIS machines can be applied for the treatment of all viral infections. Electrically generated silver ions have been shown to be effective against many viruses, including the Human Herpes, Influenza (flu) and Adenoviridae families of viruses, and to inhibit the Hepatitis B virus and the HIV-1 virus. There are no drug side effects or risks.


Support for users of the SIS equipment is backed directly by the staff of a highly specialized clinical practice and research program, conducted at the only Electromedicine Clinic & Research Lab in Australasia. When you purchase SIS equipment, you are also guaranteed ongoing, expert operation and application support.